Screening of pep tides which suppress the proliferation of transformed cells

International Journal of Oncology

Volumn 8, Issue 1, 1996, Pages 125-129

  Hiwasa, Takaki ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

Anticancer drug; MTT; Peptide

Indexed keywords

GLUTAMINYLARGINYL PROLINE; PROLYLTHREONYLTRYPTOPHAN; SYNTHETIC PEPTIDE; TRIPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GROWTH INHIBITION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

EID: 0030047760     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.1.125     Document Type: Article

References (3)

1. Hiwasa T, Yokoyama S, Ha J-M, Noguchi S and Sakiyama S: c-Ha-ras gene products are potent inhibitors of cathepsins B and L. FEBS Lett 211: 23-26, 1987.
2. Hiwasa T, Sakiyama S, Noguchi S, Ha J-M, Miyazawa T and Yokoyama S: Degradation of a cAMP-binding protein is inhibited by human c-Ha-ras gene products. Biochem Biophys Res Commun 146: 731-738, 1987.
3. Hiwasa T: Gene sharing of protease inhibitors. In: Proteases Involved in Cancer. Suzuki M and Hiwasa T (eds). Monduzzi Editore, Bologna pp 153-160, 1995.